Gilead Sciences Beats Street and Sees Sovaldi Sales Double - Presented by: The Aol. On Network

Gilead Sciences shares rose sharply in after-hours trading on Wednesday after the company reported second quarter results which surpassed analyst forecasts. The biotech company posted profits of $2.23 a share, far higher than the $1.79 analysts had been expecting. Revenue came in at $6.53 billion, that was also better than estimates. Gilead reported significant earnings per share improvement in the most recent quarter compared to the same quarter a year ago because of its Sovaldi sales. Sovaldi



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
AAPL $ 102.47 2.71 ▲ 2.72%
BAC $ 16.60 0.34 ▲ 2.09%
PBR $ 13.20 0.80 ▼ 5.71%
KO $ 40.68 2.61 ▼ 6.03%
QQQ $ 96.87 2.48 ▲ 2.63%
RF $ 9.26 0.10 ▲ 1.09%
MU $ 31.19 1.50 ▲ 5.05%
PFE $ 28.28 0.35 ▲ 1.25%

As of 10/21/2014, 04:15 PM
More Most Active